Skip to content

Drug interactions

Levoketoconazole + Netupitant-palonosetron

Severity: Moderate

Levoketoconazole and Netupitant-palonosetron: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Levoketoconazole is a strong CYP3A4 inhibitor and can raise netupitant exposure. Levoketoconazole also prolongs the QT interval, and palonosetron can have minor QT effects, so combined use carries some additional cardiac risk.

What this interaction means in plain words

Levoketoconazole and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Levoketoconazole belongs to Endocrine; Netupitant-palonosetron belongs to Gastrointestinal Tract.

Evidence level: Moderate

Why it happens

CYP3A4 inhibition of netupitant metabolism, with possible additive QT prolongation.

What to do

No netupitant dose change is needed, but monitor ECG and electrolytes in patients with QT risk factors.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Levoketoconazole and Netupitant-palonosetron, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Levoketoconazole with Netupitant-palonosetron?

MediHelp rates the interaction as moderate. Levoketoconazole and Netupitant-palonosetron can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Levoketoconazole is a strong CYP3A4 inhibitor and can raise netupitant exposure. Levoketoconazole also prolongs the QT interval, and palonosetron can have minor QT effects, so combined use carries some additional cardiac risk.

How serious is the interaction between Levoketoconazole and Netupitant-palonosetron?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No netupitant dose change is needed, but monitor ECG and electrolytes in patients with QT risk factors.

What other medicines interact with Netupitant-palonosetron?

MediHelp also lists interactions of Netupitant-palonosetron with, for example, Apomorphine, Flibanserin, Apalutamide. The full list is on the Netupitant-palonosetron page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in